ACR Meeting Abstracts

ACR Meeting Abstracts

Session » Abstracts: Infection-related Rheumatic Disease (2573–2578)

Date: Tuesday, October 28, 2025

Time: 1:00PM-2:30PM

Meeting: ACR Convergence 2025

1:00PM-1:15PM
Abstract Number: 2573
Impaired Humoral Response to Recombinant Herpes Zoster Vaccine in Rituximab Treated Autoimmune Rheumatic Diseases Patients: A Prospective Controlled Phase 4 Study
1:15PM-1:30PM
Abstract Number: 2574
Differences in SARS-CoV-2 Antigen Persistence in Individuals with Systemic Autoimmune Rheumatic Diseases Compared to the General Population
1:30PM-1:45PM
Abstract Number: 2575
Influenza and COVID-19 Vaccination Uptake Among Women with Systemic Rheumatic Diseases in New York City Assessed Between 2022 and 2024
1:45PM-2:00PM
Abstract Number: 2576
Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH) Study: Anti-inflammatory cytokine signals related to decreased arthritis disease activity over time
2:00PM-2:15PM
Abstract Number: 2577
Duration of SARS-CoV-2 Viral Shedding After Acute Infection in Patients with Rheumatic Diseases Using B Cell Depletion or Tumor Necrosis Factor Inhibitors
2:15PM-2:30PM
Abstract Number: 2578
Association of Oral Outpatient Antiviral Medications for COVID-19 with the Risk of Post-Acute Sequelae of COVID-19 in Individuals with Systemic Autoimmune Rheumatic Diseases

« View all sessions from this meeting